Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

Transcranial direct current stimulation: benefits for treatment of primary progressive aphasia

Published on: 16/12/2016 Reading time: 1 min
aphp
Retour à la recherche

Transcranial direct current stimulation could be beneficial in treating primary progressive aphasia. This is what a pre-therapeutic study recently showed, conducted by teams led by Dr. Marc Teichmann, from the Pitié-Salpêtrière AP-HP Hospital neurology department, and Antoni Valero-Cabré, research director at the French Scientific Research Center (CNRS), both at Paris Brain Institute.

Primary progressive aphasia (PPA) is a degenerative illness characterized by progressive loss of language abilities. The most common form of PPA, known as “semantic”, is defined by progressive loss of the ability to process concepts and meaning of words.

Currently, there is no confirmed treatment for aphasia independently from its origin (degenerative or post-stroke). Studies up until now were conducted on small samples (often fewer than 6 patients) or individual case studies, complicating interpretation of results.

Dr. Marc Teichmann, from the Pitié-Salpêtrière AP-HP Hospital neurology department, and Antoni Valero-Cabré, research director at the French Scientific Research Center (CNRS), both at the Institut du Cerveau - ICM, coordinated a study of twelve patients with semantic PPA. Thorough double-blind placebo-controlled methodology allowed the evaluation of transcranial direct current simulation (tDCS) effects on language and semantic skills.
tDCS is a non-invasive stimulation involving low intensity direct current that flows thanks to two electrodes places on the scalp. It does not generate any specific sensation on the stimulated area, meaning that neither patients nor doctors can differentiate active stimulation from a placebo.

Short-term clinical effects of three kinds of stimulation (anterior left temporal cortex anodal excitation; anterior right temporal cortex cathodal inhibition; placebo stimulation) were evaluated during three sessions with a week in between each session. The effects of the three forms of stimulation were then compared.

Stimulation effect was evaluated using a multidimensional semantic test. Pre/post stimulation contrast analysis, which compared left and right tDCS to placebo stimulation, demonstrated several significant effects: improved verbal semantic performance function and improved function specifically for the “living things” category. A computational model, taking into account electrode location and conductivity of the various layers of tissue (from scalp to cerebral cortex), demonstrated optimized focality of the procedure on the anterior region of the temporal lobe and efficacy of the current delivered from the scalp to the targeted cortex.

It is noteworthy that tDCS is less costly and easier to use than other non-invasive brain modulation methods such as transcranial magnetic stimulation (TMS).
This pre-therapeutic study opens up new opportunities for developing clinical applications with more durable effects for patients with degenerative aphasia. A therapeutic protocol using repeated stimulation for 10 days to induce a months-long effect with neuroplasticity mechanisms was developed and recently received AP-HP promotion. If the procedure of consecutive stimulation for several days proves useful, it can be repeated as soon as benefits begin to decrease.

In the near future, treatments using stimulation could be tailored to cranial perimeters, lesion load and distribution of individual patients, to optimize stimulation for significant and durable therapeutic effects for everyone.

Sources

https://onlinelibrary.wiley.com/doi/10.1002/ana.24766/full
Teichmann M, Lesoil C, Godard J, Vernet M, Bertrand A, Levy R, Dubois B, Lemoine L, Truong DQ, Bikson M, Kas A, Valero-Cabré A. Ann Neurol. 2016 Sep 19.

Our news on the subject

Deux nouvelles certifications pour les plateformes de l’Institut du Cerveau
Two new certifications for Paris Brain Institute’s core facilities
Paris Brain Institute’s core facilities were recently awarded two new certifications: ISO 9001 certification for ICM.Quant and ISO 20387 certification for its DNA & Cell Bank.
11.14.2025 Institutional
La dépression résistante possède une signature moléculaire spécifique
Treatment-resistant depression identified as a distinct molecular subtype
An international study published in Brain, Behavior, and Immunity shows that patients with treatment-resistant depression (TRD) have a unique biology, different from those who respond to standard therapies. More than 5,000 genes were found to behave...
11.03.2025 Research, science & health
La qualité des mitochondries durant le neurodéveloppement est cruciale pour la santé cérébrale
Mitochondrial quality during neurodevelopment is crucial for brain health
The anomalies underlying neurodegenerative diseases may arise during development—decades before the first symptoms appear. This hypothesis is gaining traction thanks to a new study published in Nature Communications. According to researchers from the...
10.20.2025 Research, science & health
La bibliothèque de Babel
Mental Time Travel: A New Case of Autobiographical Hypermnesia
Remembering past events in minute detail, revisiting them methodically, and reliving past emotions—this is the peculiarity of people with an exceptional memory of their own lives, known as autobiographical hypermnesia, or hyperthymesia. This...
08.28.2025 Research, science & health
Crédit : Ana Yael.
An International Database to Better Understand Dreams
In an article published in Nature Communications, researchers from 37 scientific institutions—including Paris Brain Institute—unveil the DREAM database: an ambitious project designed to centralize, share, and standardize data from research on sleep...
08.14.2025 Research, science & health
Troubles du Développement Intellectuel
The "RNU-Splice" project receives support from the health sponsorship of AXA Mutuals
Intellectual development disorders (IDD) affect 2 to 3 per cent of the population and are characterized by impaired cognitive functions, impacting learning. TDI thus has an impact on coping skills with implications for daily life and is a major...
10.08.2025 Support
See all our news